Evidence map›Paper›PMID 39701141›Full record

ArticlePediatrics2025

Applying Large Language Models to Assess Quality of Care: Monitoring ADHD Medication Side Effects.

Yair Bannett, Fatma Gunturkun, Malvika Pillai, Jessica E Herrmann, Ingrid Luo, Lynne C Huffman, Heidi M Feldman

Abstract read
In one paragraph

Article in Pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Timing of Medication Treatment in Children 3-5-Years-old with ADHD: A PEDSnet Study.medRxiv : the preprint server for health sciences · 2025
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Yair BannettDivision of Developmental-Behavioral Pediatrics, Stanford University School of Medicine, Stanford, California.
Fatma GunturkunStanford Quantitative Sciences Unit, Stanford, California.
Malvika PillaiVeterans Affairs Palo Alto Health Care System, Palo Alto, California.
Jessica E HerrmannStanford University School of Medicine, Stanford, California.
Ingrid LuoStanford Quantitative Sciences Unit, Stanford, California.
Lynne C HuffmanDivision of Developmental-Behavioral Pediatrics, Stanford University School of Medicine, Stanford, California.
Heidi M FeldmanDivision of Developmental-Behavioral Pediatrics, Stanford University School of Medicine, Stanford, California.

Funding

Novel Quality Measures for Primary Care Management of Attention-Deficit/Hyperactivity DisorderK23MH128455 · NIMH · STANFORD UNIVERSITY · PI Yair Bannett · 2022 to 2026
$970k
NIMH NIH HHS K23 MH128455
6 · The paper itself

Abstract

objectiveTo assess the accuracy of a large language model (LLM) in measuring clinician adherence to practice guidelines for monitoring side effects after prescribing medications for children with attention-deficit/hyperactivity disorder (ADHD).

methodsRetrospective population-based cohort study of electronic health records. Cohort included children aged 6 to 11 years with ADHD diagnosis and 2 or more ADHD medication encounters (stimulants or nonstimulants prescribed) between 2015 and 2022 in a community-based primary health care network (n = 1201). To identify documentation of side effects inquiry, we trained, tested, and deployed an open-source LLM (LLaMA) on all clinical notes from ADHD-related encounters (ADHD diagnosis or ADHD medication prescription), including in-clinic/telehealth and telephone encounters (n = 15 628 notes). Model performance was assessed using holdout and deployment test sets, compared with manual medical record review.

resultsThe LLaMA model accurately classified notes that contained side effects inquiry (sensitivity = 87.2, specificity = 86.3, area under curve = 0.93 on holdout test set). Analyses revealed no model bias in relation to patient sex or insurance. Mean age (SD) at first prescription was 8.8 (1.6) years; characteristics were mostly similar across patients with and without documented side effects inquiry. Rates of documented side effects inquiry were lower for telephone encounters than for in-clinic/telehealth encounters (51.9% vs 73.0%, P < .001). Side effects inquiry was documented in 61.4% of encounters after stimulant prescriptions and 48.5% of encounters after nonstimulant prescriptions (P = .041).

conclusionsDeploying an LLM on a variable set of clinical notes, including telephone notes, offered scalable measurement of quality of care and uncovered opportunities to improve psychopharmacological medication management in primary care.

Indexed as

Attention Deficit Disorder with HyperactivityCentral Nervous System StimulantsChildCohort StudiesElectronic Health RecordsFemaleGuideline AdherenceHumansMalePrimary Health CareQuality of Health CareRetrospective StudiesTelemedicineCentral Nervous System Stimulants

Identifiers

PMID39701141
PMCPMC11978496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.